7Baggers
Quarterly
Annual
    Unit: USD2025-05-31 2025-02-28 2024-11-30 2024-08-31 2024-05-31 2024-02-29 2023-11-30 2023-08-31 2023-05-31 2022-08-31 2022-05-31 2022-02-28 2021-11-30 2021-08-31 2021-05-31 2021-02-28 2020-11-30 2020-08-31 2020-05-31 2020-02-29 2019-11-30 2019-08-31 2019-05-31 2019-02-28 2018-11-30 2018-08-31 2018-05-31 2018-02-28 2017-11-30 2017-08-31 2017-05-31 2017-02-28 2016-11-30 2016-08-31 2016-05-31 2016-02-29 2015-11-30 2015-08-31 2015-05-31 2015-02-28 2014-11-30 2014-08-31 2014-05-31 2014-02-28 2013-11-30 2013-08-31 2013-05-31 2013-02-28 2012-11-30 2012-08-31 2012-05-31 2012-02-29 2011-11-30 2011-08-31 2011-05-31 2011-02-28 2010-11-30 2010-08-31 2010-05-31 2010-02-28 2009-11-30 2009-08-31 2009-05-31 2009-02-28 2008-11-30 2008-08-31 2008-05-31 2008-02-29 2007-11-30 2007-08-31 2007-05-31 2007-02-28 2006-11-30 2006-08-31 2006-05-31 2006-02-28 2005-11-30 2005-08-31 2005-05-31 2005-02-28 2004-11-30 2004-08-31 2004-05-31 
      
    		                                                                                   
      cash flows from (used by) operating activities:
    		                                                                                   
      net earnings
    		83,126,000 25,473,000 -175,718,000 103,931,000 119,440,000 85,847,000 176,273,000 184,166,000 233,971,000 288,630,000 312,429,000 383,314,000 232,889,000 152,313,000 130,102,000 66,357,000 64,093,000 67,623,000 64,734,000 63,798,000 83,348,000 86,111,000 78,390,000 13,850,000 19,742,000 51,560,000 39,966,000 10,170,000 36,810,000 -29,541,000 39,266,000 30,332,000 6,275,000 -131,000 19,328,000 10,502,000 25,063,000 -5,751,000 56,681,000 54,451,000 36,253,000 34,926,000 23,563,000 11,144,000 45,919,000 4,060,000 18,963,000 4,577,000 49,719,000 30,218,000 40,683,000 28,853,000 107,736,000    742,000 7,959,000 -8,463,000 -173,381,000 -31,223,000 7,180,000 -13,077,000 -35,307,000 62,006,000 63,543,000 59,484,000 39,775,000 69,164,000 104,719,000 99,441,000 65,921,000 85,350,000 128,660,000 77,960,000 80,103,000 69,624,000 83,740,000 71,741,000 56,575,000 73,725,000 47,354,000 50,884,000 
      adjustments to reconcile net earnings to cash flows from operating activities:
    		                                                                                   
      depreciation and amortization
    		72,376,000 70,584,000 70,437,000 72,190,000 70,692,000 68,299,000 69,186,000 61,302,000 55,129,000 49,081,000 43,583,000 41,134,000 41,226,000 42,437,000 41,804,000 41,573,000 41,799,000 41,654,000 41,766,000 41,391,000 40,947,000 41,054,000 41,187,000 41,248,000 35,182,000 32,216,000 33,127,000 34,123,000 32,193,000 32,022,000 32,260,000 30,499,000 30,290,000 31,517,000 31,882,000 31,550,000 31,991,000 32,950,000 32,841,000 33,129,000 33,859,000 34,874,000 33,846,000 33,424,000 33,860,000 34,384,000 34,127,000 34,286,000 33,751,000 33,369,000 34,877,000 34,036,000 35,028,000 38,766,000 39,179,000 40,988,000 40,643,000 40,541,000 40,017,000 44,681,000 43,695,000 38,634,000 37,470,000 37,267,000 41,308,000 38,475,000 32,721,000 32,351,000 31,522,000 31,446,000 26,838,000 23,855,000 25,166,000 23,856,000 21,844,000 20,408,000 19,270,000 19,854,000 18,910,000 18,708,000 19,138,000 18,716,000 18,335,000 
      stock-based compensation
    		9,546,000 8,038,000 10,232,000 9,173,000 12,846,000 14,988,000 8,059,000 16,529,000 10,376,000 9,122,000 11,986,000 16,251,000 9,619,000 8,119,000 13,800,000 12,696,000 9,062,000  6,170,000 7,536,000 8,269,000  7,343,000 5,790,000 4,217,000  4,909,000 8,558,000 4,780,000  3,560,000 7,911,000 8,245,000  6,783,000 6,840,000 6,266,000  6,466,000 6,094,000 5,728,000                                           
      write-down of inventory
    		4,930,000 6,785,000 8,950,000 -1,488,000 -3,806,000 -263,000 10,655,000 2,355,000 3,399,000                             4,238,000 9,771,000       693,000 526,000 721,000 1,063,000 4,612,000 845,000 2,553,000 5,907,000 17,910,000 2,369,000 1,409,000 3,815,000 8,523,000 8,187,000                         
      deferred income taxes and other long-term taxes
    		873,000 -18,150,000 -76,940,000 -11,253,000 -5,967,000 -19,442,000 21,343,000 17,104,000 7,885,000 21,934,000 29,261,000 40,079,000 -5,099,000 -22,698,000 -9,046,000 -19,849,000 11,720,000 1,819,000 5,619,000   13,156,000 24,662,000 12,057,000 -352,000                                                           
      litigation expense
    		3,776,000 4,720,000 350,000,000                                                                                 
      settlement of new markets tax credit transaction
    		       0 0                                                                           
      asset impairments
    		       3,734,000 1,000 453,000 3,245,000   2,439,000 277,000 474,000 3,594,000 1,098,000                                                                  
      other
    		1,059,000 2,510,000 -185,000 -939,000 1,459,000 1,123,000 1,102,000 -309,000 774,000 1,104,000 614,000 1,418,000 -583,000 298,000 348,000 -135,000 30,000 -1,917,000 362,000 396,000 1,175,000 0                                                              
      changes in operating assets and liabilities
    		-19,671,000 -67,519,000 26,248,000        -211,715,000 -196,805,000 -252,273,000  -78,839,000 -97,745,000 -140,794,000  157,492,000 -15,477,000 -196,000  5,387,000 -44,476,000 -36,333,000  -49,995,000                                                         
      net cash flows from operating activities
    		154,400,000 32,441,000 213,024,000 351,817,000 197,870,000 88,961,000 261,060,000 409,424,000 375,772,000 458,562,000 187,379,000   134,242,000 93,029,000           67,035,000 42,858,000   155,558,000 6,931,000   79,997,000        42,635,000                 4,024,000 -18,420,000 31,891,000         338,928,000 34,586,000 45,732,000 42,044,000 136,635,000          
      cash flows from (used by) investing activities:
    		                                                                                   
      capital expenditures
    		-89,450,000 -86,267,000 -118,187,000 -81,468,000 -82,031,000 -93,781,000 -66,991,000 -166,923,000 -150,491,000 -155,642,000 -102,784,000 -121,412,000 -70,150,000 -56,770,000 -39,707,000 -50,487,000 -37,201,000 -53,526,000 -37,500,000 -51,033,000 -45,559,000 -47,083,000 -24,256,000 -29,583,000 -37,914,000 -30,387,000 -43,240,000 -41,347,000 -59,681,000 -51,038,000 -71,274,000 -47,843,000 -42,965,000 -58,851,000 -42,044,000 -51,268,000 -11,169,000 -43,604,000 -26,478,000 -27,048,000 -22,450,000 -34,031,000 -31,495,000 -22,138,000 -14,085,000 -26,027,000 -21,159,000 -17,092,000 -24,757,000 -31,348,000 -29,132,000 -23,448,000 -29,925,000 -21,676,000 -28,472,000 -11,163,000 -11,904,000 -17,657,000 -22,118,000 -40,832,000 -46,514,000 -79,376,000 -80,701,000 -122,963,000 -86,654,000                   
      free cash flows
    		                                                                                   
      proceeds from government assistance related to property, plant and equipment
    		0                                                                                   
      proceeds from the sale of property, plant and equipment
    		169,000 103,000 5,167,000              743,000 -2,248,000 87,000 4,353,000 9,651,000 1,407,000 461,000                                                             
      net cash flows used by investing activities
    		-87,477,000 -61,657,000 -113,487,000 -82,055,000 -82,487,000 -91,987,000 -66,473,000 -230,065,000  -155,972,000   -68,732,000             -49,817,000 40,117,000 2,623,000 -63,598,000 93,416,000 -113,214,000 -68,264,000 -25,653,000 -25,542,000 -41,583,000 -100,166,000 -8,356,000     -38,592,000                        -325,245,000 -91,643,000                 
      cash flows from (used by) financing activities:
    		                                                                                   
      proceeds from issuance of long-term debt
    		         2,988,000 0   92,000 12,937,000   39,973,000 11,267,000   0 0 0 180,000,000                     0         824,000 594,000 45,000 1,000 944,000 20,799,000 694,000             313,000 8,142,000 -5,366,000 11,406,000     0 38,400,000 
      repayments of long-term debt
    		-10,162,000 -9,301,000 -10,940,000 -8,862,000 -10,285,000 -7,923,000 -9,276,000 -9,056,000 -220,437,000 -8,888,000 -6,532,000 -306,618,000 -6,556,000 -6,672,000 -4,063,000 -353,969,000 -3,823,000 -136,053,000 -3,590,000 -53,582,000 -53,298,000 -103,566,000 -9,533,000 -7,430,000 -7,175,000                                                           
      debt issuance costs
    		-568,000 0 -38,000     0 0 0 -87,000   0 -1,706,000           0                                                          
      proceeds from accounts receivable facilities
    		16,455,000 0 13,303,000 33,307,000 103,936,000 28,658,000 9,421,000 87,653,000 167,445,000 112,571,000 136,935,000 40,066,000 150,664,000 150,722,000                                                                      
      repayments under accounts receivable facilities
    		-16,455,000 0 -13,303,000 -61,063,000 -76,591,000 -28,222,000 -17,471,000 -104,910,000 -166,262,000 -143,270,000 -75,470,000 -70,490,000 -144,706,000 -151,546,000                                                                      
      treasury stock acquired
    		-50,421,000 -48,016,000 -50,417,000 -54,768,000 -51,817,000 -47,939,000 -28,408,000 -18,567,000 -16,516,000 -106,283,000 -38,587,000 -11,699,000 -5,311,000                     0 0 -26,040,000 -4,555,000 0 -2,226,000 -30,239,000 -9,341,000                     0 0 0 -18,514,000 -20,782,000 0 -100,339,000 -51,191,000 -41,425,000 0       -26,402,000      
      tax withholdings related to share settlements, net of purchase plans
    		705,000 9,304,000 -19,560,000 968,000 664,000 10,308,000 -19,535,000 1,126,000 1,124,000                                                                           
      dividends
    		-20,319,000 -20,427,000 -20,554,000 -20,679,000 -20,815,000 -18,626,000 -18,748,000 -18,679,000 -18,733,000 -16,746,000 -16,992,000 -16,986,000 -17,025,000 -14,471,000 -14,462,000 -14,427,000 -14,406,000  -14,288,000 -14,242,000 -14,238,000  -14,206,000 -14,065,000 -14,116,000                                                           
      contribution from non-controlling interest
    		   0    0                                                                            
      net cash flows used by financing activities
    		66,971,000 -68,440,000 -101,509,000  -54,901,000 -63,744,000 -84,017,000      -39,305,000 -21,233,000 20,910,000 -80,497,000 -28,570,000           -21,121,000 -24,351,000 -271,307,000 -13,912,000 -15,244,000 -24,030,000 -20,229,000   -58,886,000              -44,354,000 -27,021,000 -992,000   -102,449,000 -50,094,000                           
      effect of exchange rate changes on cash
    		1,808,000 194,000 -695,000 380,000 131,000 -439,000 819,000 107,000 425,000 -923,000 -579,000 -733,000 -550,000 -367,000 -4,000 -54,000 -365,000 549,000 -127,000 141,000 196,000 -257,000 -120,000 132,000 -353,000 -242,000 -710,000 484,000 -235,000 -850,000 427,000 950,000 -1,740,000 -537,000 436,000 -713,000 -466,000 -1,605,000 -309,000 -1,654,000 -1,980,000 -60,000 377,000 -466,000 1,022,000 -1,344,000 -677,000 218,000 1,525,000 3,687,000 -8,072,000 5,261,000 -7,658,000 -631,000 1,474,000 1,948,000 1,081,000 1,142,000 -3,155,000 -589,000 397,000 877,000 490,000 -949,000 -5,946,000  1,277,000 713,000 1,465,000   -96,000 471,000  1,571,000 1,525,000 -354,000 -132,000 -905,000 340,000 1,314,000 30,000 2,105,000 
      increase in cash, restricted cash and cash equivalents
    		135,702,000 -97,462,000 -2,667,000  60,613,000 -67,209,000 111,389,000  -129,733,000  -463,171,000    77,280,000 -98,152,000 -77,481,000  230,284,000 8,023,000 32,130,000                                                               
      cash, restricted cash and cash equivalents at beginning of period
    		0 0 859,555,000 0 0 0 595,717,000 0 0 0 0 0 501,129,000  0 0 544,964,000  0 0 193,729,000  0 0 632,615,000                                                           
      cash, restricted cash and cash equivalents at end of period
    		135,702,000 -97,462,000 856,888,000 159,045,000 60,613,000 -67,209,000 707,106,000 117,032,000 -129,733,000 142,714,000 -463,171,000 581,379,000 418,321,000  77,280,000 -98,152,000 467,483,000  230,284,000 8,023,000 225,859,000  54,143,000 10,626,000 57,537,000                                                           
      adjustments to reconcile net earnings to net cash flows from operating activities:
    		                                                                                   
      net gain on sales of assets
    		       1,152,000                                                                            
      loss on debt extinguishment
    		       1,000 0 0 0   0 0                   0 115,000           3,256,000                                      
      settlement of new markets tax credit transactions
    		                                                                                   
      changes in operating assets and liabilities, net of acquisitions:
    		                                                                                   
      accounts receivable
    		                             8,141,000 -88,830,000 -27,923,000 30,085,000 -3,656,000 -44,456,000 23,961,000 166,661,000 116,221,000 -47,720,000 37,646,000 100,486,000 -83,918,000 -79,674,000 -52,857,000 73,052,000 23,254,000 -16,974,000                   21,116,000 -218,764,000   19,988,000 -101,828,000 -96,267,000 138,412,000 -99,384,000 -123,402,000 -87,240,000 12,102,000 -4,697,000 -130,503,000 -35,769,000 -46,429,000 44,624,000 -125,741,000 
      inventories
    		                             35,885,000 -66,264,000 -79,134,000 10,678,000 3,838,000 94,173,000 32,844,000 78,700,000 162,422,000 140,755,000 -149,476,000 -102,954,000 -565,000 37,552,000 -184,529,000 -29,789,000 58,780,000 52,519,000                   -175,893,000 -190,260,000   138,712,000 -56,640,000 -1,675,000 -90,778,000 -25,782,000 47,553,000 -105,424,000 47,457,000 35,101,000 14,841,000 2,842,000 -102,097,000 -127,651,000 -21,306,000 
      accounts payable, accrued expenses and other payables
    		                             10,123,000 73,981,000 79,764,000 -70,390,000 21,099,000 50,326,000 -38,553,000 -76,449,000 -51,195,000 31,306,000 -99,336,000 -61,292,000 52,276,000 60,189,000 9,673,000 -31,534,000 60,655,000                                      
      other operating assets and liabilities
    		                                                                                   
      acquisitions, net of cash acquired
    		       -67,648,000 -101,916,000 0        -8,287,000 0   0 41,000 -6,180,000 -694,802,000                                 0 0 0 -2,448,000 0     -9,606,000 -2,283,000 -18,757,000               
      proceeds from government grants related to property, plant and equipment
    		                                                                                   
      proceeds from insurance
    		       0 0 0 0           0 500,000                                                             
      proceeds from the sale of property, plant and equipment and other
    		       230,000 245,000 177,000 5,408,000 308,145,000 1,418,000 534,000 5,552,000          1,953,000  5,684,000 71,000 560,000  1,184,000 521,000 179,000 1,643,000 410,000 247,000 2,813,000 4,782,000 1,870,000 7,391,000 882,000 10,799,000 392,000 4,255,000 2,126,000 2,740,000 4,267,000 941,000 5,956,000 43,989,000 3,274,000 1,083,000 7,014,000 1,141,000 381,000 354,000 51,518,000 17,600,000 4,831,000 273,000 183,000 328,000 -2,550,000 4,044,000 798,000                   
      debt issuance and extinguishment
    		                                                                                   
      net cash flows from (used by) financing activities
    		       -62,434,000 -253,370,000 -158,953,000 -146,000       -115,061,000 -10,593,000 -42,776,000 -79,360,000   41,432,000 140,342,000 -18,091,000            -135,405,000 -105,151,000 68,116,000 -8,251,000 -6,268,000 -21,740,000 -26,292,000 19,903,000 -180,077,000 206,506,000 -42,925,000 31,526,000     -29,146,000            467,756,000                  
      increase in cash and cash equivalents
    		                         -1,115,000      -69,621,000 -52,377,000    151,865,000 104,317,000 68,005,000 -13,074,000 -108,850,000 -2,285,000 5,456,000 -83,719,000 136,703,000 -74,499,000   8,974,000 28,763,000   5,713,000     109,683,000    -35,786,000    150,448,000    346,150,000   -23,368,000 57,541,000   14,074,000   45,301,000 -79,685,000   
      changes in operating assets and liabilities, net of acquisitions
    		    3,206,000 -61,591,000 -25,558,000  63,449,000                                                                           
      debt extinguishment costs
    		       -1,000 0 0 0   0 -77,000                    -114,000           -3,055,000                                      
      amortization of acquired unfavorable contract backlog
    		             -1,495,000 -1,508,000 -1,509,000 -1,523,000 -10,691,000 -4,348,000 -5,997,000 -8,331,000 -16,582,000 -23,394,000 -23,476,000 -11,332,000                                                           
      net gain on disposals of assets
    		                                                                                   
      net cash flows from (used by) investing activities
    		                        -357,444,000              -24,608,000 -20,148,000 -18,723,000   -19,872,000 42,306,000  -16,892,000 -16,151,000 10,194,000  -25,858,000 8,904,000 -23,776,000  -28,956,000 -7,455,000 38,091,000                           
      net gain on disposals of subsidiaries, assets and other
    		             583,000 -3,909,000 -5,412,000 -69,000  109,000 1,148,000 -6,733,000    -1,271,000                                                           
      adjustments to reconcile net earnings to cash flows from (used by) operating activities:
    		                                                                                   
      stock issued under incentive and purchase plans, net of forfeitures
    		          587,000 5,652,000 -16,371,000 641,000 729,000 5,805,000 -10,341,000 -1,499,000 542,000 5,354,000 -7,817,000 488,000 492,000 3,364,000 -6,220,000 534,000 -2,442,000 2,126,000 -9,520,000 18,000 -108,000 2,253,000 -7,661,000 2,000 -365,000 1,957,000 -7,628,000 -103,000 -12,000 1,604,000 -2,981,000 -628,000 -120,000 1,349,000 -2,089,000 -396,000 -1,006,000 2,767,000 -414,000                                   
      net gain on disposals of assets and other
    		                                                                                   
      net cash flows from (used by) operating activities
    		            25,779,000    -12,088,000 259,371,000 278,417,000 106,998,000 146,418,000            -954,000   113,237,000 219,573,000  198,073,000 -59,388,000 -79,896,000   -37,089,000 73,472,000  94,235,000 -42,441,000 -34,271,000  95,761,000 935,000 38,139,000  -28,652,000 -9,823,000 -5,591,000     137,712,000 379,760,000 285,072,000 3,992,000 10,113,000 -4,038,000 -7,062,000 -42,469,000       -46,588,000 71,663,000       
      decrease in cash, restricted cash and cash equivalents
    		            -82,808,000           10,626,000 -575,078,000                                                           
      beneficial interest in securitized accounts receivable
    		                     0 0 0 -367,521,000                                                           
      contribution from noncontrolling interest
    		             1,000 0                                                                     
      cash, restricted cash and cash equivalents at beginning of year
    		                                                                                   
      cash, restricted cash and cash equivalents at end of year
    		                                                                                   
      net cash flows used by investing activities:
    		              -36,655,000 -30,892,000 -36,458,000  -37,413,000 -56,340,000 -35,124,000                                                               
      proceeds from accounts receivable programs
    		               4,361,000 4,487,000 63,349,000 85,447,000 58,636,000 27,050,000 65,753,000 83,073,000                                                             
      repayments under accounts receivable programs
    		               -4,361,000 -4,487,000  -89,971,000 -50,257,000 -31,057,000                                                               
      share-based compensation
    		                                         1,997,000 5,266,000 5,244,000 5,544,000 5,165,000 6,343,000 2,676,000 4,509,000 3,929,000 3,223,000 2,092,000 3,881,000  3,214,000 3,891,000 2,135,000 7,542,000 15,000 3,153,000 2,422,000 5,106,000 3,603,000 4,657,000 4,109,000 4,194,000 5,734,000 4,862,000 4,206,000 5,118,000 2,023,000 3,059,000 2,299,000 2,551,000 2,551,000 2,491,000 1,933,000       
      net gain on sales of a subsidiary, assets and other
    		                                                                                   
      write-down of inventory and other
    		                                                                                   
      benefit from losses on receivables
    		                     288,000    317,000 145,000 147,000 1,901,000 5,193,000 -525,000 -147,000 1,528,000 3,130,000 1,008,000 669,000 2,071,000 956,000 1,254,000 1,366,000 -95,000 -55,000   -240,000    1,153,000              10,237,000 14,594,000 8,784,000  2,822,000 819,000 605,000  598,000 -592,000 633,000 514,000 321,000 1,159,000 682,000 3,030,000 562,000 2,057,000 955,000 711,000 1,653,000 
      proceeds from insurance, sale of discontinued operations and other
    		                 0 0 190,000 784,000                                                               
      advances under accounts receivable programs
    		                                                                                   
      cash dividends
    		                         -14,040,000 -14,041,000 -14,002,000 -13,993,000 -13,895,000 -13,893,000 -13,864,000 -13,862,000 -13,756,000 -13,747,000 -13,861,000 -13,978,000 -13,872,000 -13,889,000 -14,034,000 -14,150,000 -14,138,000 -14,130,000 -14,093,000 -14,067,000 -14,038,000 -14,027,000 -14,000,000 -13,963,000 -13,960,000 -13,905,000 -13,889,000 -13,863,000 -13,864,000 -13,853,000 -13,738,000 -13,722,000 -13,716,000 -13,703,000 -13,555,000 -13,515,000 -13,503,000 -13,502,000 -13,481,000 -13,653,000                   
      contribution from noncontrolling interests
    		                  0       0 0   0 1,000    0                                                 
      deferred income taxes
    		                    27,939,000        9,312,000 -11,646,000 6,842,000 3,038,000 -12,418,000 -13,633,000 14,358,000 9,444,000 -14,058,000 -3,105,000 5,995,000 21,236,000 -835,000 3,788,000 10,010,000 -531,000 19,081,000 10,284,000 15,009,000 5,486,000 23,876,000 7,498,000 40,321,000 4,419,000 -112,237,000 -21,213,000 2,084,000 -799,000 72,000         8,782,000 -5,110,000   -5,424,000 -3,043,000 -2,462,000 326,000 -31,674,000 -2,150,000 -1,285,000 650,000 -8,889,000 -15,000 -15,000 -15,000 1,576,000 -408,000 
      net (gain) loss on sales of a subsidiary, assets and other
    		                                                                                   
      amortization of interest rate swaps termination gain
    		                             -5,959,000 -1,900,000 -1,899,000 -1,899,000 -1,899,000 -1,900,000 -1,899,000 -1,899,000 -1,899,000 -1,899,000 -1,900,000 -1,899,000 -1,899,000 -1,899,000 -1,899,000 -1,900,000 -3,747,000 -2,908,000 -2,907,000 -2,908,000                                   
      proceeds from the sale of discontinued operations and other
    		                     0 0                                                             
      write-down of inventories
    		                      314,000 192,000 45,000  62,000 1,209,000 87,000  615,000 697,000 508,000  1,618,000 5,292,000 2,657,000                                               
      asset impairment
    		                          1,491,000 11,294,000 1,480,000  69,000 91,000 462,000      3,241,000    0 222,000 1,005,000  406,000 0 3,028,000 1,688,000 600,000 -16,000 1,044,000     2,428,000 242,000    0    121,000    0             
      net cash flows used by operating activities
    		                      134,390,000 4,736,000 -357,623,000    -34,202,000                                                   51,368,000 -78,504,000   
      net cash flows from (used by) investing activities:
    		                      -23,254,000                                                             
      net cash flows from financing activities
    		                                                                                   
      net (gain) loss on disposals of subsidiaries, assets and other
    		                                                                                   
      benefit from losses on (recovery of) receivables
    		                                                                                   
      increase in documentary letters of credit
    		                         0 8,000 -2,131,000 2,141,000 -547,000 574,000 -325,000 320,000 -1,323,000 -14,330,000 -16,063,000 -9,752,000     8,768,000 -1,782,000 -13,896,000 18,663,000 -6,616,000 5,663,000 -65,485,000 60,217,000   -6,959,000 13,080,000         -80,791,000    -19,564,000    -2,998,000   -7,007,000 40,610,000 994,000 -2,988,000 -37,889,000 -14,446,000 12,527,000 17,918,000 8,289,000 -26,071,000 -1,126,000 
      proceeds from settlement of life insurance policies
    		                        1,905,000 2,375,000 0                                                         
      insurance proceeds
    		                        2,000,000                                                           
      proceeds from the sale of subsidiaries
    		                        1,893,000  68,077,000 5,146,000 2,260,000   0 524,000                                                   
      proceeds from the accounts receivable programs
    		                        33,439,000                                                           
      tax expense from stock plans
    		                                                                                   
      proceeds (payments) on sale of accounts receivable programs
    		                                                                                   
      acquisitions
    		                         0 0   -1,655,000                                                      
      proceeds from long-term debt transactions
    		                                                                                   
      short-term borrowings, net change
    		                                 0 0 0 -20,090,000 15,294,000 -346,000 4,612,000 -11,758,000 7,648,000 -3,898,000 545,000 2,020,000 6,071,000 -47,465,000 34,915,000 -13,045,000 -19,484,000 -2,179,000 -4,162,000 44,432,000 -2,000,000 -8,856,000 -78,524,000 79,127,000 -46,681,000 -21,142,000 80,968,000 1,491,000 -633,000 2,286,000 -23,876,000 -4,021,000 -35,990,000 -3,746,000 3,950,000 34,359,000 -194,875,000 192,787,000 -49,102,000 -10,898,000 43,537,000    -5,000 -10,164,000     
      deferred income taxes & other long-term taxes
    		                          15,249,000                                                         
      decrease in restricted cash
    		                          9,596,000 13,753,000 243,000    16,609,000 0 0 0 1,000  -238,000    -268,000 1,005,000 17,300,000                                       
      repayments on long-term debt
    		                          -5,276,000 -7,127,000 -2,979,000  -2,627,000 -2,987,000 -3,161,000 -2,789,000 -2,789,000 -202,907,000 -2,909,000 -3,297,000 -2,690,000 -2,904,000 -2,444,000 -2,851,000 -1,683,000 -1,592,000 -1,551,000 -141,414,000 -61,040,000 -1,118,000 -1,284,000 -1,259,000 -15,340,000 -3,618,000 -44,584,000 -10,104,000 -8,486,000 -7,597,000 -7,390,000 -10,025,000 -5,456,000 -6,891,000 -7,567,000 -29,692,000 -785,000 -101,727,000 -292,000                   
      proceeds from new markets tax credit transactions
    		                                                                                   
      cash and cash equivalents at beginning of year
    		                          0 0 252,595,000 0 0 0 517,544,000 0 0 0 485,323,000 0 0 0 434,925,000 0 0 0 378,770,000 0 0 0 262,422,000 0 0 0 222,390,000 0 0 0 399,313,000 0 0 0 405,603,000 0 0 0 219,026,000 0 0 0 419,275,000 0 0 0 180,719,000 0 0 0 119,404,000 0 0 0 123,559,000 0 0 
      cash and cash equivalents at end of period
    		                          405,260,000 64,975,000 130,209,000  -119,768,000 -69,621,000 465,167,000  102,177,000 -255,510,000 637,188,000  68,005,000 -13,074,000 326,075,000  5,456,000 -83,719,000 515,473,000  283,172,000 -101,299,000 271,396,000  17,477,000 -11,921,000 228,103,000  -21,459,000 -117,779,000 382,800,000  -7,523,000 -36,877,000 334,030,000  326,931,000 22,979,000 91,479,000  -6,857,000 -180,371,000 255,806,000  -3,040,000 -81,186,000 157,351,000  51,067,000 -61,367,000 133,478,000  -20,968,000 45,301,000 43,874,000  1,441,000 
      supplemental information:
    		                                                                                   
      noncash activities:
    		                                                                                   
      liabilities related to additions of property, plant and equipment
    		                          -2,122,000 -18,352,000 48,726,000 20,306,000 -4,160,000 14,982,000 20,202,000 11,697,000                                                  
      net (gain) loss on disposals of assets and other
    		                           746,000 -228,000                                                       
      decrease in cash and cash equivalents
    		                           64,975,000 -122,386,000      102,177,000                    -21,459,000 -117,779,000 -16,513,000   -36,877,000 -71,573,000   22,979,000 -127,547,000   -180,371,000 -163,469,000              1,441,000 
      tax benefit from stock plans
    		                                -334,000  -611,000 -30,000 -25,000                                               
      changes in operating assets and liabilities:
    		                            -120,537,000                                                       
      asset acquisition
    		                            -6,980,000                                                       
      increase in restricted cash
    		                                 27,317,000 51,000                                                 
      cash and cash equivalents at end of year
    		                                                                                   
      noncash activities-
    		                                                                                   
      proceeds (payments) on sales of accounts receivable programs
    		                              775,000                                                     
      changes in other operating assets and liabilities
    		                              7,230,000 -17,019,000 -12,294,000                                                   
      decrease (increase) in restricted cash
    		                              -13,541,000                                                     
      net gain on sales of assets and other
    		                                    -2,830,000                                               
      net (gain) loss on sales of assets and other
    		                                41,000                                                   
      advance payments on sale of accounts receivable program
    		                                8,269,000                                                   
      net gain on sale of a subsidiary, cost method investment and other
    		                                         -3,324,000 14,000 -2,982,000 -25,064,000                                       
      advance payments on sale of accounts receivable programs
    		                                   826,000 10,678,000                                               
      debt issuance and extinguishment costs
    		                                                                                   
      contribution from (purchase of) noncontrolling interests
    		                                     0 0   22,000 0 15,000 -52,000 0 3,000 -5,000 15,000                                   
      net gain on sale of assets and other
    		                                  965,000               -10,798,000               -214,000   291,000 -189,000   -25,000 -3,000  -486,000 -66,000 -1,032,000  -200,000 -265,000 -735,000   
      other assets
    		                                  -9,410,000 6,644,000 -3,963,000 12,619,000 7,423,000 -172,000 3,804,000 -2,030,000 -4,172,000 5,871,000 -20,185,000 -2,234,000 -6,333,000                   -67,987,000 -39,037,000   -7,355,000 -24,019,000 -49,031,000 -8,927,000 -7,787,000 -17,134,000 -19,018,000 -4,559,000 -968,000 -535,000 -6,798,000 1,304,000 179,000 -13,823,000 
      other long-term liabilities
    		                                  4,068,000 13,719,000 -5,290,000 -4,063,000 -538,000 -793,000 -4,270,000 -1,299,000 -1,381,000 -4,368,000 505,000 -3,048,000 3,364,000                   -4,765,000 5,899,000   853,000 8,956,000 1,473,000 18,200,000 5,168,000 -433,000 5,290,000 7,772,000 6,217,000 3,289,000 4,304,000 4,689,000 1,711,000 5,872,000 
      change in liabilities related to purchases of property, plant, and equipment
    		                                                                                   
      change in liabilities related to purchases of property, plant and equipment
    		                                    7,562,000                                               
      tax expense from stock-based plans
    		                                                                                   
      proceeds from the sale of cost method investment
    		                                             0 0 0 28,995,000                                   
      payments for debt issuance costs
    		                                         -1,000 0 0 -430,000 -559,000                                      
      tax benefits from stock plans
    		                                      -76,000 -33,000 -13,000  -141,000 -375,000 -109,000  -5,000   -1,910,000 -26,000   12,000 -65,000 -2,231,000 -71,000 -7,237,000 597,000 1,902,000 705,000 -546,000 126,000 828,000 518,000 4,308,000 2,573,000 3,220,000 881,000 5,237,000 6,589,000 2,081,000 2,987,000 10,596,000 918,000 7,683,000 2,043,000 1,374,000 2,641,000 6,576,000 1,592,000 1,886,000 2,790,000 
      net gain on sale of a subsidiary and other
    		                                      277,000 -1,547,000 -467,000                                           
      accounts receivable sold
    		                                      -47,704,000 37,872,000 -88,201,000 -3,458,000 -25,417,000 146,505,000 3,327,000      -80,604,000 56,710,000 47,785,000          10,839,000   -2,398,000 10,377,000   53,961,000 -33,544,000 82,709,000 12,546,000      14,825,000 26,059,000 179,000 42,958,000 -20,704,000 
      proceeds from the sale of a subsidiary
    		                                      0 -491,000 2,845,000  0 -1,989,000 54,265,000                                       
      documentary letters of credit, net change
    		                                      -85,826,000 105,138,000 32,410,000                                           
      capital lease additions and changes in accounts payable related to purchases of property, plant and equipment
    		                                      4,363,000 2,457,000 5,062,000                                           
      purchase of noncontrolling interests
    		                                                  -5,000 -11,000 -30,000  -407,000                             
      tax benefit from stock-based plans
    		                                                                                   
      decrease in deposit for letters of credit
    		                                                                                   
      proceeds from termination of interest rate swaps
    		                                                 0                                  
      tax benefit (expense) from stock-based plans
    		                                                                                   
      benefit from losses (recoveries) on receivables
    		                                                 -3,248,000 1,401,000 -855,000 239,000     -751,000   -2,526,000                       
      accounts receivable sold (repurchased)
    		                                             -78,288,000 35,005,000 9,317,000 -46,614,000       13,094,000 21,994,000 -19,083,000   -10,456,000                       
      proceeds from the sale of equity method investments
    		                                                     6,578,000 0                             
      decrease (increase) in deposit for letters of credit
    		                                                 649,000 0                                 
      tax benefit (expense) from stock plans
    		                                                                                   
      net gain on sale of cost method investment and other
    		                                                                                   
      net (gain) loss on sale of cost method investment and other
    		                                               -451,000 -26,071,000                                   
      accounts payable, accrued expenses, other payables and income taxes
    		                                                                 123,965,000 331,428,000   -4,320,000 115,220,000 12,729,000 -145,808,000 144,230,000 51,724,000 57,572,000 -82,481,000 71,254,000 62,667,000 -20,396,000 -29,768,000 90,294,000 91,486,000 
      decrease in accounts receivable
    		                                                81,217,000           9,155,000 58,328,000                       
      increase in inventories
    		                                                -100,139,000    -24,786,000  -73,750,000       60,473,000 154,400,000 238,402,000 80,621,000    -31,923,000               
      decrease (increase) in other assets
    		                                                -740,000       40,451,000 291,000                           
      decrease in accounts payable, accrued expenses, other payables and income taxes
    		                                                -56,228,000    -121,167,000    -35,710,000    -37,242,000   -189,238,000 -356,366,000    -111,415,000               
      increase in other long-term liabilities
    		                                                113,000 -1,990,000 11,276,000 3,861,000 -2,704,000  -2,129,000 9,365,000 1,208,000    2,040,000 1,986,000 18,860,000 -7,995,000 -20,107,000    13,003,000               
      increase in deposit for letters of credit
    		                                                    -865,000 -865,000 -865,000 -870,000 -1,523,000 308,000 -71,000                         
      decrease (increase) in accounts receivable
    		                                                 64,103,000   94,061,000   -25,547,000 -16,233,000 873,000                          
      decrease (increase) in inventories
    		                                                        -22,428,000 -18,732,000 -22,702,000                         
      increase in accounts payable, accrued expenses, other payables and income taxes
    		                                                 -11,125,000 38,190,000   23,470,000 33,112,000   49,398,000 131,517,000   24,667,000                      
      decrease in other assets
    		                                                  -7,495,000 19,463,000 2,978,000            -2,081,000                   
      decrease in documentary letters of credit
    		                                                      65,283,000 -11,410,000 -108,614,000  46,660,000 -41,694,000 -37,850,000   -11,826,000 -2,934,000   -2,332,000 -7,060,000               
      stock issued under incentive and purchase plans
    		                                                  -71,000 1,586,000 -27,000 -447,000 105,000 9,568,000 389,000 139,000 1,066,000 8,329,000 960,000 2,189,000 -283,000 1,313,000 65,000 -3,659,000 -239,000 12,471,000 337,000 -2,952,000 -223,000 12,734,000 1,290,000 -2,433,000 4,920,000 19,509,000 1,663,000 1,696,000 2,886,000 12,402,000 1,719,000 3,611,000 3,010,000 
      net (gain) loss on sale of assets and other
    		                                                   -270,000 374,000     -4,211,000                          
      increase in accounts receivable
    		                                                             14,784,000 282,117,000 223,083,000 172,402,000    -29,337,000               
      decrease in other long-term liabilities
    		                                                          -5,808,000                         
      net income
    		                                                      36,220,000                             
      adjustments to reconcile net income to cash from (used by) operating activities:
    		                                                                                   
      recoveries on receivables
    		                                                        -522,000                           
      gain on sale of assets and other
    		                                                        -1,527,000                           
      (gain) loss on sale of assets and other
    		                                                                                   
      adjustments to reconcile net earnings to cash from (used by) operating activities:
    		                                                                                   
      contract losses
    		                                                                                   
      decrease in deferred income taxes
    		                                                             -44,967,000                      
      net cash used by investing activities
    		                                                          -17,358,000 -67,726,000 -48,779,000  -83,251,000 -118,919,000 -86,762,000    -87,647,000 -92,360,000 -253,226,000 -58,659,000 -26,668,000 -65,999,000 -38,574,000 -31,814,000 -29,114,000 -51,569,000 -25,428,000 -22,056,000 -18,437,000 -19,784,000 -16,479,000 
      net cash from (used by) financing activities
    		                                                                         -13,006,000 16,397,000 15,510,000 -28,121,000 -64,455,000    -49,177,000  
      net income on sale of assets and other
    		                                                              -107,000                     
      contract loss reserves
    		                                                                                   
      accounts receivable repurchased
    		                                                                                   
      increase in deferred income taxes
    		                                                           20,716,000 -8,933,000   -6,504,000 9,087,000    -25,368,000               
      net cash used by financing activities
    		                                                           49,858,000 -55,082,000   -142,225,000 -38,831,000    -34,818,000   -68,163,000 -39,215,000           
      writedown of inventory
    		                                                            12,931,000 16,645,000 49,086,000                     
      decrease in inventories
    		                                                            15,010,000                       
      increase in other assets
    		                                                            -12,155,000 28,574,000 4,359,000      -1,324,000               
      minority interests
    		                                                             -63,000 -370,000 -163,000 46,000 -2,000 277,000 391,000 -128,000 -76,000 387,000 4,648,000 4,628,000 7,472,000 3,070,000 -578,000 245,000 662,000 -2,354,000 -1,910,000 2,858,000   
      net income on sale of assets
    		                                                                                   
      asset impairment charges
    		                                                                                   
      cash flows used by investing activities:
    		                                                                                   
      purchase of minority interests in cmc zawiercie
    		                                                             0 0    -39,000                 
      proceeds from issuance of long term debt
    		                                                              29,821,000                     
      acquisitions of other businesses, net of cash acquired
    		                                                               6,000 -906,000                   
      decrease in accounts receivable sold
    		                                                                4,397,000    38,715,000               
      net (gain) loss on sale of assets
    		                                                                     305,000              
      purchase of interests in cmc zawiercie and subsidiaries
    		                                                                                   
      payments on trade financing arrangements
    		                                                                         0 0 -55,000 -1,612,000 -6,011,000 -4,933,000 -5,860,000 -5,518,000   
      effect of exchange rate changes on cash and cash equivalents
    		                                                                     121,000              
      changes in operating assets and liabilities, net of effect of acquisitions:
    		                                                                                   
      purchases of property, plant and equipment
    		                                                                  -82,795,000 -75,257,000 -69,189,000 -84,488,000 -46,674,000 -48,269,000 -26,831,000 -38,608,000 -33,167,000 -32,355,000 -27,105,000 -42,330,000 -27,743,000 -22,926,000 -17,215,000 -18,674,000 -18,643,000 
      sales of property, plant and equipment
    		                                                                  797,000 364,000 299,000  797,000 243,000 224,000  1,367,000 564,000 3,108,000  2,315,000 870,000 1,728,000   
      payments on long-term debt
    		                                                                  -503,000 272,000 -1,473,000 -53,257,000 -238,000 -275,000 -18,512,000 -19,777,000   -240,000 -15,781,000 -1,018,000 -357,000 -66,000 -42,430,000 1,266,000 
      dividends paid
    		                                                                  -13,693,000 -13,958,000 -10,671,000 -10,773,000 -10,733,000 -10,673,000 -7,075,000 -7,190,000 -6,017,000 -3,513,000 -3,492,000 -3,506,000 -3,627,000 -3,587,000 -2,932,000 -2,922,000 -2,322,000 
      purchase of interests in cmc zawiercie subsidiary
    		                                                                        -61,000           
      adjustments to reconcile net earnings to cash from operating activities:
    		                                                                                   
      sales of property, plant and equipment and other
    		                                                                                   
      purchase of interests in cmc zawiercie
    		                                                                                   
      net cash from financing activities
    		                                                                               15,649,000 15,942,000   
      acquisitions of fabrication businesses
    		                                                                           -23,000 -5,117,000  0     
      loss on reacquisition of debt
    		                                                                                 0 0 
      net gain on sale of assets
    		                                                                                   
      acquisitions of cmc zawiercie and lofland, net of cash acquired
    		                                                                                   
      proceeds from trade financing arrangements
    		                                                                                   
      debt reacquisition and issuance costs
    		                                                                                 0 0 
      business interruption insurance recovery
    		                                                                               -600,000 -3,900,000   
      acquisitions of cmcz and lofland, net of cash acquired
    		                                                                                 0 392,000 
      acquisitions of fabrication businesses, net of cash acquired
    		                                                                                   
      asset impairment charge
    		                                                                                   
      acquisitions of lofland and cmcz, net of cash acquired
    		                                                                                   
      adjustments to reconcile net earnings to cash used by operating activities:
    		                                                                                   
      changes in operating assets and liabilities, net of effect of acquisition:
    		                                                                                   
      acquisition of fabrication business
    		                                                                                -2,950,000   
      short-term borrowings
    		                                                                                14,450,000   
      changes in operating assets and liabilities, net of effect of acquisitions and sale of smi-owen:
    		                                                                                   
      sale of assets of smi-owen
    		                                                                                   
      minority interest
    		                                                                                  6,941,000 
      net gain on sale of property and other
    		                                                                                  -407,000 
      net cash used by operating activities
    		                                                                                  -1,488,000 
      sale of property, plant and equipment
    		                                                                                  1,772,000 
      acquisition of symons’ denver, co. business
    		                                                                                   
      payments on short-term trade financing arrangement
    		                                                                                  -3,000,000 
      notes payable — cmcz
    		                                                                                   
      proceeds from notes payable — cmcz
    		                                                                                   
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.